SCHEMBL10446629

SCHEMBL10446629

CCc1ncc2cc(C(=O)OC)c(=O)[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 8/20 0.45
▸ DYRK1B Q9Y463 8/20 0.45
▸ CNR2 P34972 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ FOS P01100 1/20 0.37
▸ JUN P05412 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ SPR P35270 1/20 0.36
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10446512 0.86 KDM4E (0.41) DYRK1ADYRK1BCNR2KDM4EGAA
SCHEMBL10323239 0.81 DYRK1A (0.64) DYRK1ADYRK1B
SCHEMBL10446504 0.81 DYRK1A (0.53) DYRK1ADYRK1BMAPTALDH1A1LMNA
SCHEMBL10323979 0.78 DYRK1A (0.45) DYRK1ADYRK1BCNR2KDM4EGLA
SCHEMBL10323118 0.76 ALDH1A1 (0.55) KDM4EGAAMAPTALDH1A1LMNA
SCHEMBL10324214 0.74 POLB (0.45) DYRK1ADYRK1BKDM4EMAPTALDH1A1
SCHEMBL10446240 0.73 DYRK1A (0.48) DYRK1ADYRK1BMAPT
SCHEMBL10446237 0.72 DYRK1A (0.45) DYRK1ADYRK1BMAPTALDH1A1L3MBTL1
SCHEMBL20589469 0.72 SYK (0.52) GAAMAPTALDH1A1LMNAL3MBTL1
SCHEMBL10323700 0.72 ALDH1A1 (0.43) DYRK1ADYRK1BGAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD DYRK1A 654/4885DYRK1B 570/4885CNR2 3243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback